Clal Biotechnology reported ILS47.21M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
aTyr Pharma USD 60M 11M Feb/2026
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
RedHill Biopharma USD 12M 17M Jun/2024